The number of women who've tried magnesium, felt nothing, and written it off entirely is genuinely frustrating — because the research on this mineral in perimenopause is actually pretty compelling. The form really is everything. Switching from oxide to glycinate was the difference between nothing and noticeably better sleep for a lot of women who share their stories here. It's worth getting specific.
Learn more about Rose →Magnesium oxide is the form found in the majority of budget supplements and multivitamins, largely because it contains a high percentage of elemental magnesium by weight — around 60%. The problem is that its bioavailability sits at roughly 4%, meaning the body absorbs very little of what's listed on the label. For women already dealing with the magnesium-depleting effects of elevated cortisol and disrupted sleep in perimenopause, oxide is unlikely to move the needle on any symptom.
Magnesium glycinate is magnesium bound to glycine, an amino acid with its own calming properties — which makes this pairing particularly well-suited to the sleep disruption and anxiety that track closely with perimenopause. Its absorption rate is significantly higher than oxide, and because it doesn't draw water into the bowel, it's well tolerated at the doses needed to have an effect. Clinical and observational data consistently point to glycinate as the preferred form when the target symptoms are insomnia, nervous system dysregulation, or mood instability.
Magnesium L-threonate was developed specifically to increase magnesium concentrations in the brain, and preclinical studies show it does this more effectively than other forms. For women experiencing cognitive symptoms — word-finding difficulties, poor concentration, or memory lapses — threonate is the most physiologically targeted option available. Human trial data is still emerging and sample sizes are small, so this one sits at a B-to-C evidence grade for cognitive benefit specifically, but the mechanism is sound.
Magnesium citrate has decent bioavailability — notably better than oxide — and is well absorbed in the gut, which also explains its well-known laxative effect at higher doses. For women whose main concern is the constipation that often worsens in perimenopause, citrate can be genuinely useful. However, for sleep, mood, or muscle symptoms, it isn't the most targeted choice, and the digestive effect can make higher doses difficult to sustain.
Magnesium malate combines magnesium with malic acid, a compound involved in the cellular energy cycle (the Krebs cycle), which makes this form particularly relevant for women dealing with muscle aches, fatigue, or the deep physical tiredness that often appears in perimenopause. Some fibromyalgia research supports its use for musculoskeletal pain, and while the menopause-specific evidence is limited, the mechanism aligns well with these symptoms. Women who find other forms do nothing for physical exhaustion or widespread body aches are often better served by malate.
Magnesium taurate pairs magnesium with taurine, an amino acid that plays a role in cardiovascular function and blood pressure regulation. This matters in menopause because the decline in oestrogen removes a protective effect on the cardiovascular system, and blood pressure often climbs in the late perimenopause years. The evidence base for taurate specifically is still small, but both magnesium and taurine independently show benefit for vascular health, making this form worth noting for women whose primary concerns are heart palpitations or rising blood pressure.
Magnesium chloride is highly bioavailable in oral form and is also the compound used in topical magnesium products — sprays, oils, and flakes. The evidence for transdermal absorption of magnesium is genuinely contested: some small studies show measurable increases in serum magnesium after skin application, but methodological limitations mean this shouldn't be relied upon as a primary delivery method. Orally, chloride is a reasonable and well-absorbed option; as a topical for muscle soreness or relaxation, it may offer localised benefit even if systemic absorption is uncertain.
The milligram figure on a supplement label typically refers to the total weight of the magnesium compound, not the amount of actual magnesium (elemental magnesium) it delivers. A 500mg capsule of magnesium oxide contains roughly 300mg of elemental magnesium, while a 500mg capsule of magnesium glycinate may contain only 50–100mg of elemental magnesium — the rest is glycine. This distinction matters because dosing recommendations (typically 300–400mg of elemental magnesium per day for adult women) refer to elemental magnesium, and many women are unknowingly under-dosing despite taking what looks like a large amount.
Choosing the correct magnesium form is the first step, but absorption is also influenced by vitamin D status, B6 levels, and whether magnesium is taken with or without food. Low vitamin D — extremely common in perimenopausal women — impairs magnesium absorption and also depletes magnesium reserves independently, creating a compounding deficit. Taking magnesium glycinate in the evening with a small amount of food, and ensuring adequate vitamin D, removes the most common reasons a well-chosen form still fails to deliver results.
Rose covers every symptom, supplement, and condition in full detail — evidence-graded and agenda-free.
Rose is a free, evidence-based reference built for women navigating perimenopause and menopause. No ads. No products to sell. No agenda. Just honest answers — because every woman in this season deserves a trusted friend who has done the research.